Medicines Manufacturing Data Institute: Phase 1

Résumé

This is a Phase 1 project call from Innovate UK for UK registered organisations to establish the Medicines Manufacturing Data Institute (MMDI). The funding envelope is up to £500,000 with a deadline of 14 October 2026.

This call is for establishing a Medicines Manufacturing Data Institute focused on pharmaceutical production and data management, which is fundamentally misaligned with Acme Corporation's semiconductor and AI domain. While the call does involve data and digital aspects, it targets healthcare/pharma manufacturing rather than semiconductors, AI, or any of the client's stated strategic priorities.

Scores détaillés

Pas d'analyse approfondie — ce score ≤ 6,0 n'a pas déclenché l'analyse détaillée. Voir l'analyse d'adéquation ci-dessus.

Description

UK registered organisations can apply for a share of up to £500,000 for a phase 1 project to establish the Medicines Manufacturing Data Institute (MMDI). This funding is from Innovate UK.